In recent years, more and more studies have shown that bulk folic acid has an important role in the treatment of hypertension. This article describes the role and mechanism of action of folic acid in the treatment of hypertension. It includes the effect of folic acid on homocysteine metabolism, the protection of vascular endothelial function and other aspects. Through the comprehensive analysis of related studies, it provides new ideas and methods for the treatment of hypertension.

INTRODUCTION
Hypertension is one of the most common cardiovascular diseases worldwide. It is also a major risk factor for serious complications such as cardiovascular and renal diseases. Although a wide range of antihypertensive drugs are available. However, there are still some patients with unsatisfactory blood pressure control. In recent years, with the in-depth study of the pathogenesis of hypertension, the role of bulk folic acid in the treatment of hypertension has gradually received attention.
Overview of folic acid
• Chemical structure and properties of folic acid
Folic acid is also known as vitamin B9. Folic acid bulk powder is a water-soluble vitamin. Its chemical name is pteroylglutamic acid. Folic acid consists of pteridine, p-aminobenzoic acid and glutamic acid. It is involved in the transfer and metabolism of one-carbon units in the cell.
• Sources of folic acid and its absorption by the body
Folic acid is widely found in a variety of foods. For example, green leafy vegetables, beans, nuts and liver. Absorption of bulk folic acid by the body occurs mainly in the upper part of the small intestine through specific carriers and transport proteins.
Relationship between folic acid and hypertension
• Hyperhomocysteinemia and hypertension
Homocysteine (Hcy) is a sulfur-containing amino acid. Its metabolism depends on nutrients such as folic acid and vitamin B12. When the body is deficient in folic acid, Hcy's metabolism is blocked. This leads to increased blood levels of Hcy, resulting in hyperhomocysteinemia (HHcy). Numerous studies have shown that HHcy is closely related to the development of hypertension. It is one of the independent risk factors for hypertension.
• Epidemiological studies on folic acid deficiency and hypertension
Several epidemiological surveys have shown that bulk folic acid deficiency is common among hypertensive patients. And folic acid level is negatively correlated with blood pressure. Folic acid supplementation can reduce the incidence of hypertension and blood pressure levels.
Role in the treatment of hypertension
• Lowering blood pressure
Numerous clinical studies have confirmed that folic acid supplementation can significantly reduce the blood pressure level of hypertensive patients. The effect is especially obvious in patients with HHcy. The effect of folic acid in lowering blood pressure may be related to its mechanism of improving vascular endothelial function and inhibiting oxidative stress.
• Prevention
Cardiovascular and cerebrovascular complications Hypertensive patients are often associated with an increased risk of cardiovascular and cerebrovascular complications. Such as coronary heart disease, stroke, etc. Folic acid vitamin b9 powder reduces oxidative stress and endothelial damage by lowering Hcy levels. This will reduce the risk of cardiovascular events.
• Improve kidney function
Hypertension can lead to kidney damage. Bulk folic acid can reduce oxidative stress and inflammatory response in the kidney, protect kidney function, and slow down the progress of hypertensive nephropathy.
Mechanism of action
• Involved in homocysteine metabolism
There are two main pathways for the metabolism of Hcy in the body. One is under the catalysis of methionine synthase, with vitamin B12 as a cofactor, it combines with the methyl group provided by 5-methyltetrahydrofolate to regenerate methionine.
The second is the combination with serine to produce cystathionine, which in turn produces cysteine, under the action of cystathionine β-synthase. Folic acid, as a carrier of one-carbon units, is involved in the conversion of Hcy to methionine. When folic acid is deficient, Hcy metabolism is impaired, resulting in increased blood levels of Hcy. Supplementation of folic acid can promote the metabolism of Hcy and reduce its level, thus exerting antihypertensive effects.
• Protection of vascular endothelial function
Vascular endothelial cells play an important role in regulating vascular tone and maintaining stable blood pressure. Hypertension can lead to vascular endothelial cell damage, causing endothelial dysfunction. Folic acid can improve vascular endothelium-dependent diastolic function by increasing the synthesis and release of nitric oxide (NO), reducing vascular resistance and thus lowering blood pressure. In addition, bulk folic acid can inhibit the inflammatory response and oxidative stress of endothelial cells, reduce apoptosis of endothelial cells, and protect the integrity of vascular endothelium.

• Inhibit oxidative stress
Oxidative stress plays an important role in the development of hypertension. In hypertensive patients, the generation of reactive oxygen species (ROS) increases and the antioxidant capacity decreases, leading to oxidative damage. Folic acid has an antioxidant effect, which can scavenge free radicals and reduce the damage of oxidative stress on vascular endothelial cells and cardiomyocytes. At the same time, pure folic acid powder can also regulate the activity of antioxidant enzymes, such as superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and so on, to enhance the body's antioxidant capacity.
• Suppression of oxidative stress
Oxidative stress plays an important role in the development of hypertension. Patients with hypertension have increased generation of reactive oxygen species (ROS) and decreased antioxidant capacity, leading to oxidative damage. Bulk folic acid has an antioxidant effect, which can scavenge free radicals and reduce the damage of oxidative stress on vascular endothelial cells and cardiomyocytes. At the same time, folic acid can also regulate the activity of antioxidant enzymes, such as superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and so on, to enhance the body's antioxidant capacity.
• Regulation of renin-angiotensin-aldosterone system (RAAS)
RAAS plays a key role in blood pressure regulation. When hypertension occurs, the RAAS system is activated, leading to an increase in the production of angiotensin II (Ang II) and an increase in the secretion of aldosterone, causing vasoconstriction and sodium retention, thus raising blood pressure. Folic acid can inhibit the activation of the RAAS system, reduce the production of Ang II and the secretion of aldosterone, and play a role in lowering blood pressure.
• Influence on gene expression
Folic acid can affect gene expression by participating in the DNA methylation process. The altered methylation status of hypertension-related genes may be related to the development of hypertension. Supplementation of folic acid can correct the methylation abnormality of genes, thus regulating blood pressure.
Clinical application
• Applicable people
Folic acid treatment of hypertension is mainly applicable to patients with HHcy. For general hypertensive patients, whether to supplement folic acid should be evaluated individually.
• Dosage and duration of treatment
The current recommended dose of bulk folic acid powder supplementation is 0.4-0.8 mg/d. For patients with hypertension associated with HHcy, the dose can be increased appropriately. Folic acid supplementation is generally longer, usually lasting several months or even years.
• Combination therapy
Folic acid is often used in combination with antihypertensive drugs to improve the effect of lowering blood pressure. Commonly used combination regimens include folic acid and angiotensin-converting enzyme inhibitors (ACEIs), angiotensin II receptor antagonists (ARBs), calcium channel blockers (CCBs), and so on.
• Evaluation of efficacy
Evaluation of the efficacy of pure folic acid powder in the treatment of hypertension mainly includes the monitoring of blood pressure levels, the determination of Hcy levels and the occurrence of cardiovascular and cerebrovascular complications.
Folic acid plays an important role in the treatment of hypertension. Its mechanism of action involves participation in homocysteine metabolism, protection of vascular endothelial function, inhibition of oxidative stress, regulation of the RAAS system and influence on gene expression. Although the current research on the treatment of hypertension with folic acid has made some progress. However, there are still some problems to be further solved. For example, the optimal bulk folic acid supplementation dose and treatment course, the synergistic effect of folic acid and other nutrients, and the individual differences in treating hypertension with folic acid.
Guanjie Biotech is specializing in bulk folic acid for 20 years. Our folic acid products are high quality and competitive price. Welcome to enquiry us: info@gybiotech.com.
References:
[1] Wang X, Qin X, Demirtas H, et al. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis[J]. Lancet, 2007, 369(9576): 1876-1882.
[2] Huo Y, Li J, Qin X, et al. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial[J]. JAMA, 2015, 313(13): 1325-1335.
[3] Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis[J]. JAMA, 2002, 288(16): 2015-2022.
[4] Zhang W, Sun K, Chen J, et al. Association of homocysteine with hypertension and prehypertension in a Chinese rural population[J]. PLoS One, 2013, 8(11): e79488.
[5] Yang B, Liu Y, Xu Y, et al. Homocysteine and hypertension in a Chinese population: a cross-sectional study[J]. PLoS One, 2013, 8(10): e77987.
[6] Xu Y, Wang L, He J, et al. Prevalence and control of hypertension in China: the China Hypertension Survey, 2012-2015[J]. Circulation, 2018, 137(22): 2344-2356.
[7] Zhang Y, Li W, Yan T, et al. Homocysteine, folic acid and cardiovascular diseases: meta-analyses of randomized controlled trials and cohort studies[J]. BMC Med, 2019, 17(1): 165.
[8] Liu M, Li X, Zhang Y, et al. Folic acid supplementation for stroke prevention in patients with hypertension: a systematic review and meta-analysis[J]. PLoS One, 2017, 12(8): e0182877.






